IL6 and breast cancer: Furthermore, the top upregulated pathway in aneuploid cB-ALL samples was IL6 JAK-STAT3 signaling (Fig. 7E,F and Dataset EV2), which has been recently involved in adaptation of breast cancer cells to CIN (Hong et al, 2022).